An acute dose of nicotine enhances cue-induced cocaine craving

Drug and Alcohol Dependence

Volumn 49, Issue 2, 1998, Pages 95-104

  Reid, Malcolm S ^a   Mickalian, Joanne D ^b   Delucchi, Kevin L ^b   Hall, Sharon M ^b   Berger, S Paul ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Cocaine; Craving; Cue induced; Nicotine; Relapse

Indexed keywords

COCAINE; NICOTINE;

ADULT; AGED; ANXIETY; ARTICLE; ASSOCIATION; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONDITIONING; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SKIN CONDUCTANCE; SKIN TEMPERATURE; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH;

ADULT; ANALYSIS OF VARIANCE; ANXIETY; BEHAVIOR, ADDICTIVE; COCAINE-RELATED DISORDERS; CONDITIONING (PSYCHOLOGY); CRACK COCAINE; CROSS-OVER STUDIES; CUES; DOUBLE-BLIND METHOD; DRIVE; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SKIN TEMPERATURE; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 0031912410     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)00144-0     Document Type: Article

References (40)

1. Benowitz N.L., Peyton J., Fong I., Suneel G. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 268:1994;296-303.
2. Berger S.P., Hall S.M., Mickalian J.D., Reid M.S., Crawford C.A., Delucchi K.L., Carr K., Hall S. Haloperidol antagonism of cue-elicited cocaine craving. Lancet. 347:1996;504-508.
3. Budney A.J., Higgins S.T., Hughes J.R., Bickel W.K. Nicotine and caffeine use in cocaine-dependent individuals. J. Subst. Abuse Treat. 5:1993;117-130.
4. Cgegler L.L., Mark H. Cardiovascular dangers of cocaine abuse. Am. J. Cardiol. 57:1986;1185-1186.
5. Childress A.R., McLellan A.T., O'Brien C.P. Conditioned responses in a methadone population: a comparison of laboratory, clinic and natural setting. J. Subst. Abuse Treat. 3:1986;173-179.
6. DiChiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences, USA. 85:1988;5274-5278.
7. Ehrman R.N., Robbins S.J., Childress A.R., O'Brien C.P. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology. 107:1992;523-529.
8. Ettinger N.A., Albin R.J. A review of the respiratory effects of smoking cocaine. Am. J. Med. 87:1989;664-668.
9. Fagerström K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 3:1978;235-241.
10. Fibiger, H.C., Phillips, A.G., 1987. Role of catecholamine transmitters in brain reward systems: implications for the neurobiology of affect. In: Engel, J., Oreland, L., (Eds.), Brain Reward Systems and Abuse. Raven Press, New York, pp. 61-74.
11. Foltin R.W., Fischman M.W. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J. Pharmacol. Exp. Ther. 257:1991;247-261.
12. Frawley P.J., Smith J.W. One-year follow-up after multimodal inpatient treatment for cocaine and methamphetamine dependencies. J. Subst. Abuse Treat. 9:1992;271-286.
13. Hansson L., Choudry N.B., Karlsson J.A., Fuller R.W. Inhaled nicotine in humans: effect on respiratory and cardiovascular systems. J. Appl. Physiol. 76:1994;2420-2427.
14. Henningfield J.E., Griffiths R.R. Cigarette smoking and the subjective response: effects of d-amphetamine. Clin. Pharmacol. Ther. 30:1981;497-505.
15. Henningfield J.E., Clayton R., Pollin W. Involvement of tobacco in alcoholism and illicit drug use. Br. J. Addict. 85:1990;279-292.
16. Higgins S.T., Bickel W.K., Hughes J.R., Lynn M., Capeless M.A. Effects of intranasal cocaine on human learning, performance and physiology. Psychopharmacology. 102:1990;451-458.
17. Higgins S.T., Delany D.D., Budney A.J., Bickel W.K., Hughes J., Foerg F., Fenwick J.A. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psych. 148:1991;1218-1224.
18. Horger B.A., Giles M.K., Schenk S. Pre-exposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology. 107:1992;271-276.
19. Hori T., Hayashi M., Oka M., Agari I., Kawabe K., Takagi M. Re-examination of arousing and de-arousing effects of cigarette smoking. Percep. Motor Skills. 78:1994;787-800.
20. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132:1986;337-338.
21. Keller-Stanislawski B., Caspary S., Merz P-G., Bonn R., Wolf M., Reitbrock N. Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine. Int. J. Clin. Pharmacol. Ther. Toxicol. 31:1993;417-421.
22. Kranzler H.R., Bauer L.O. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. Br. J. Addict. 87:1992;1537-1548.
23. Kreek, M.J., 1987. Multiple drug use patterns and their consequences. In: Meltzer, M.Y. (Ed.), Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp. 1597-1604.
24. Low R.B., Jones M., Carte B., Cadoret R.J. The effect of d-amphetamine and ephidrine on smoking attitude and behavior. Addict. Behav. 9:1984;335-345.
25. Lyness W.H., Friedle N.M., Moore K.E. Destruction of dopaminergic nerve terminals in nucleus accumbens: effects on d-amphetamine self-administration. Pharmacol. Biochem. Behav. 11:1979;553-556.
26. Lyvers M., Miyata Y. Effects of cigarette smoking on electrodermal orienting reflexes to stimulus change and stimulus significance. Psychophysiology. 30:1993;231-236.
27. McLellan A.T., Luborsky L., O'Brien C.P., Woody G.E. An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. J. Nerv. Ment. Dis. 168:1980;26-33.
28. McNair, D.M., Lorr, M., Droppelman, L.F., 1971. Manual: Profile of Mood States. Educational and Industrial Testing Service, San Diego, CA.
29. Nemeth-Coslett R., Henningfield J., Katz J., Goldberg S. Effect of cocaine on rate of cigarette smoking. Pharmacol. Biochem. Behav. 25:1986;300.
30. O'Brien C.P., Childress A.R., McLellan T., Ehrman R. Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. Addict. Behav. 15:1990;355-365.
31. O'Brien C.P., Childress A.R., McLellan A.T., Ehrman R. Classical conditioning in drug-dependent humans. Ann. New York Acad. Sci. 654:1992;400-415.
32. Robbins S.J., Ehrman R.N., Childress A.R., O'Brien C.P. Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. Addict. Behav. 17:1992;491-499.
33. Roberts D.C.S., Corcoran M.E., Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6:1977;615-620.
34. Rohsenow D.J., Niara R.S., Childress A.R., Abrams D.B., Monti P.M. Cue reactivity in addictive behaviors: theoretical and treatment implications. Int. J. Addict. 25:1991;975-993.
35. Schnoll S.H., Daghestani A.N., Karrigan J., Kitchen S.B., Hansen T. Characteristics of cocaine abusers presenting for treatment. NIDA Res. Monogr. Ser. 61:1985;171-181.
36. Sees K.L., Clark H.W. Substance abusers want to stop smoking! Alcohol. Clin. Exp. Res. 15:1991;152.
37. Sees K.L., Clark H.W. When to begin smoking cessation in substance abusers. J. Subst. Abuse Treat. 10:1993;189-195.
38. Smith J.W., Frawley P.J. Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews. J. Subst. Abuse Treat. 11:1993;359-369.
39. US Department of Health and Human Services, 1988. The health consequences of smoking: nicotine addiction: A Report of The Surgeon General. (DHHS Publication No. CDC 8-8406), US Government Printing Office, Washington, D.C.
40. Wesnes K., Warburton D.M. Smoking, nicotine and human performance. Pharmacol. Ther. 21:1983;189-208.